Zoll Medical Corp has donated $10 million to the non-profit Zoll Foundation in December 2020 to support research and educational activities for resuscitation and acute critical care, according to Zoll’s parent company Asahi Kasei.
Established in 2013 by Zoll, the Zoll Foundation is a non-profit charitable organization that provides grants to support the development of promising new technology and therapies from around the globe to improve the prognosis of patients. To date, the Zoll Foundation has provided grants totaling $2.5M (USD) to 69 young investigators hailing from 14 countries.
“It has been very rewarding to provide grants to many dedicated young researchers in the area of resuscitation and acute critical care since we saw the need and established the Foundation to support them,” said Ward M. Hamilton, President of the ZOLL Foundation. “We believe our support is contributing to a new generation of researchers who will drive science ahead in these fields and become the mentors of next generation of researchers in the future.”
“I have seen firsthand how the Zoll Foundation helps young researchers. Even during the pandemic, it has continued to provide grants to support research that plays a critical role in advancing science and biotechnology,” says Fumito Ichinose, MD, PhD, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts. Three current and past trainees in Dr. Ichinose’s laboratory were awarded Zoll Foundation grants over the past three years (2018-2020).
Along with Zoll, Asahi Kasei has made ongoing donations to the Zoll Foundation since its launch eight years ago and will continue to support the research and education for resuscitation and acute critical care through grants as part of its mission to “contribute to life and living for people around the world.” For more information about the grant eligibility and application form for the upcoming spring deadline of March 31, please visit http://zollfoundation.org/apply.html. Applications are accepted online for March 31 and September 30 deadlines each year.
